Losing weight can support better heart health, but now doctors are warning of their possible impacts on your heart.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

This charming old-school diner isn’t just a place to grab a quick bite; it’s a portal to a bygone era where soda jerks ruled ...

Valentine’s Day represents a perfect opportunity to highlight news and updates from across biopharma that have hearts a | ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

Recent reports reveal heart disease is the leading cause of death in the U.S., many of whom are younger than 45. Here's what ...

A simple scoring system could revolutionize how doctors prevent heart attacks and strokes by identifying patients most likely ...

The FDA has accepted for review the BLA for lerodalcibep to reduce LDL-C in patients with or high risk of ASCVD and primary hyperlipidemia.

Heart transplant is a scary and serious surgery with high cost, but for patients with heart failure it can be the only option for cure.

Use of secondary cardiovascular disease (CVD) prevention medications has improved little over time, according to a ...